๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Agents, biomarkers, and cohorts for chemopreventive agent development in prostate cancer

โœ Scribed by Gary J Kelloff; Ronald Lieberman; Vernon E Steele; Charles W Boone; Ronald A Lubet; Levy Kopelovich; Winfred A Malone; James A Crowell; Howard R Higley; Caroline C Sigman


Book ID
117263354
Publisher
Elsevier Science
Year
2001
Tongue
English
Weight
136 KB
Volume
57
Category
Article
ISSN
0090-4295

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Introductory remarks: Development of che
โœ Gary J. Kelloff; Charles W. Boone; Winfred F. Malone; Vernon E. Steele; Linda A. ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 699 KB

The term "cancer chemoprevention" refers to the prevention of cancer by intervening with drugs prior to the malignant ( k . , invasive) stage of carcinogenesis. The development of chemopreventive drugs is the major objective of the Chemoprevention Branch at the National Cancer Institute. The testin

Development of chemopreventive agents fo
โœ Gary J. Kelloff; Charles W. Boone; Winfred F. Malone; Vernon E. Steele; Linda A. ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 943 KB

The term cancerchemoprevention refers to the prevention or prolongation of carcinogenesis by intervention with drugs prior to the malignant (i.e., invasive) stage. The development of chemopreventive drugs is the major objective of the Chemoprevention Branch of the National Cancer Institute. Neoplast